Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression.

Yeh, Chi-Hsiao

Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. [electronic resource] - Journal of cardiovascular pharmacology Apr 2005 - 301-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0160-2446

10.1097/01.fjc.0000155385.41479.b3 doi


Animals
Curcumin--pharmacology
Gene Expression Regulation--drug effects
Male
Matrix Metalloproteinases--biosynthesis
Myocardial Contraction--drug effects
Myocardial Reperfusion Injury--metabolism
Myocytes, Cardiac--drug effects
NF-kappa B--antagonists & inhibitors
Rabbits
Up-Regulation--drug effects